Montelukast Prescribing at THE RISE GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
382
Total Quantity
7,960
NHS Cost
£419
vs National Avg
-44.2%
THE RISE GROUP PRACTICE prescribed 382 items of Montelukast over the last 12 months at a cost of £419 to the NHS. This is 44.2% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
28
Jul 2026
37
Jul 2026
22
Jul 2026
37
Jul 2026
38
Jul 2026
33
Jul 2026
40
Jul 2026
30
Jul 2026
31
Jul 2026
30
Jul 2026
27
Jul 2026
29
Prescribing Details
| Total Items | 382 |
|---|---|
| Total Quantity | 7,960 |
| Total NHS Cost | £419 |
| Presentations | 3 different forms |
| vs National Average | -44.2% |
Montelukast Prescribing Comparison
| This practice | 382 items |
|---|---|
| National average per practice | 685 items |
| Difference | -44.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.